Precigen, Inc.
NASDAQPrecigen heads into its November earnings with shorts gradually unwinding, retail attention spiking, and a freshly initiated analyst coverage expanding the bull case, even as the stock slips 6% on the week. Short interest remains elevated but is clearly declining. Bears hold 11.3% of the free float short, down from roughly 11.8% a month ago and continuing a steady bleed since…
Snapshot as of 10 Oct 2026
Precigen heads into its November earnings with shorts gradually unwinding, retail attention spiking, and a freshly initiated analyst coverage expanding the bull case, even as the stock slips 6% on the week. Short…
PGEN heads into its August 12 earnings event with a striking divergence: the stock is up 18% on the week and analysts are raising targets, yet C-suite insiders have been selling consistently into every rally. The…
PGEN heads into its June 18 earnings call with short sellers in an extended retreat — but still holding a position large enough to keep the stock structurally contested. Short interest has fallen from a peak above…
PGEN enters the post-earnings window with an interesting tension: a stock still down 6% on the week, a short position that has been quietly unwinding, and a Q1 revenue beat that confirms Papzimeos is ramping faster…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PGEN — free to start on ORTEX.
Sign up for free →Open PGEN on ORTEX